National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Hepatitis B trials
The registry lists 15 Hepatitis B studies with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor. 1 are open to participants now and 6 have results posted.
Phase 2 5Phase 3 3Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Patients With Liver DiseaseRecruitingNCT00001971
- Add-on Peginterferon Following Nucleos(t)Ide Analogue TreatmentCompletedNCT02364336Phase 2Results posted
- Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis BCompletedNCT01369212Phase 3Results posted
- Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis BTerminatedNCT01369199Phase 3Results posted
- Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT01368497Phase 3Results posted
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis BTerminatedNCT00524173Phase 2Results posted
- Lamivudine and Adefovir to Treat Chronic Hepatitis BCompletedNCT00023309Phase 2Results posted
- Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)CompletedNCT05621304
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnNCT03575208Phase 2
- Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C InfectionCompletedNCT03248622
- Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis BCompletedNCT01581554
- Duration of Long-term Immunity After Hepatitis B Virus ImmunizationCompletedNCT01182311
- Long-Term Lamivudine Therapy for Chronic Hepatitis BCompletedNCT00120354Phase 4
- Prevention of Recurrent Hepatitis B After Liver TransplantationCompletedNCT00059267
- Lamivudine for Chronic Hepatitis BCompletedNCT00001457Phase 2